Simon Pedder - Sep 8, 2025 Form 4 Insider Report for ADAPTIN BIO, INC.

Role
Executive Chairman, Director, 10%+ Owner
Signature
/s/ S. Halle Vakani, Attorney-in-Fact
Transactions as of
Sep 8, 2025
Transactions value $
$0
Form type
4
Date filed
9/10/2025, 04:59 PM
Previous filing
Feb 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pedder Simon Executive Chairman, Director, 10%+ Owner 3540 TORINGDON WAY, SUITE 200, #250, CHARLOTTE /s/ S. Halle Vakani, Attorney-in-Fact 2025-09-10 0001316736

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding Common Stock 929K Sep 8, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction Stock Option (right to buy) Award $0 +192K $0.00 192K Sep 8, 2025 Common Stock 192K $4.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025.